About the Authors

Atul T. Patel

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Kansas City Bone and Joint Clinic, Overland Park, KS, United States of America

Mark F. Lew

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Department of Neurology, Keck/University of Southern California School of Medicine, Los Angeles, CA, United States of America

Khashayar Dashtipour

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Department of Neurology/Movement Disorders, Loma Linda University, Loma Linda, CA, United States of America

Stuart Isaacson

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Parkinson’s Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL, United States of America

Robert A. Hauser

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation University of South Florida Health Byrd Institute, Parkinson’s Disease and Movement Disorders Center of Excellence, Tampa, FL, United States of America

William Ondo

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Methodist Neurological Institute, Houston, TX, United States of America

Pascal Maisonobe

Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Ipsen, Boulogne-Billancourt, France

Stefan Wietek

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Stefanwietek15@gmail.com

Affiliation Formerly of Ipsen, Cambridge, MA, United States of America

Bruce Rubin

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Formerly of Ipsen, Cambridge, MA, United States of America

Allison Brashear

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation University of California Davis School of Medicine, Sacramento, CA, United States of America

Competing Interests

I, A. T. Patel, have read the journal’s policy and the authors of this manuscript have the following competing interests: Speaker: Allergan, Ipsen, Merz, Revance; Research support: Allergan, Ipsen, Revance. I, M. F. Lew, have read the journal’s policy and the authors of this manuscript have the following competing interests: Advisor/consultant/speaker: AbbVie, ACADIA, Acorda, Adamas, Cynapsus, Kyowa Kirin, Lundbeck, Neurocrine, Revance, Teva, US WorldMeds; Researcher: Biotie, Enterin Inc., Michael J. Fox Foundation, Parkinson Study Group, Pharm2B; I, A. Brashear, have read the journal’s policy and the authors of this manuscript have the following competing interests: Consulting: Ipsen, Revance; Research support: paid to Wake Forest (institution) and conflicts were managed by Wake Forest. I, K. Dashtipour, have read the journal’s policy and the authors of this manuscript have the following competing interests: Advisor/consultant, and/or speaker: AbbVie, ACADIA, Acorda, Adamas, Allergan, Amneal, Impax, Ipsen, Lundbeck, Neurocrine, Revance, Sunovion, Teva, US WorldMeds. I, S. Isaacson, have read the journal’s policy and the authors of this manuscript have the following competing interests: Honoraria for CME/consultant/promotional speaker: AbbVie, ACADIA, Acorda, Adamas, Addex, Allergan, Amarantus, Axovant, Biogen, Britannia, Eli Lilly, Enterin, GE Healthcare, Global Kinetics, Impax, Intec Pharma, Ipsen, Kyowa, Lundbeck, Michael J. Fox Foundation, Neurocrine, Neuroderm, Parkinson Study Group, Pharma2B, Roche, Sanofi, Sunovion, Teva, UCB, US WorldMeds, Zambon; Honoraria for research grants: AbbVie, ACADIA, Acorda, Adamas, Addex, Allergan, Amarantus, Axovant, Biogen, Britannia, Eli Lilly, Enterin, GE Healthcare, Global Kinetics, Impax, Intec Pharma, Ipsen, Kyowa, Lundbeck, Michael J. Fox Foundation, Neurocrine, Neuroderm, Parkinson Study Group, Pharma2B, Roche, Sanofi, Sunovion, Teva, UCB, US WorldMeds. I, R. A. Hauser, have read the journal’s policy and the authors of this manuscript have the following competing interests: Consulting: AbbVie, Academy for Continued Healthcare Learning, ACADIA, Acorda, Adamas, AstraZeneca, Back Bay Life Science, Biotie, Bracket, Cerecor, ClearView Healthcare Partners, ClinicalMind Medical and Therapeutic Communications, Cowen and Company, Cynapsus Therapeutics, Decision Resources Group, Eli Lilly, eResearch Technology, Expert Connect, Extera Partners, GE Healthcare, Gerson Lehrman Group, Globe Life Sciences, Guidepoint Global, Health Advances, Health and Wellness Partners, HealthLogix, Huron Consulting Group, Impax, Intec Pharma, Jazz Pharmaceuticals, Kyowa Kirin Pharmaceutical Development, LCN Consulting, LifeMax, The Lockwood Group, Lundbeck, MEDACorp, Medscape, Medtronic, Michael J. Fox Foundation, Movement Disorder Society, National Institutes of Health (NIH), Neurocrine Biosciences, Neuroderm, Neuropore Therapies, Outcomes Insights, Parkinson Foundation, Peerview Press, Pennside Partners, Pfizer, Pharma2B, Phase Five Communications, Piper Jaffray & Co, Prexton Therapeutics, Projects in Knowledge, Putnam Associates, Quintiles, RMEI Medical Education for Better Outcomes, Sarepta Therapeutics, Schlesinger Associates, Scion Neurostim, Seagrove Partners, Slingshot Insights, Sun Pharma, Sunovion, Teva, US WorldMeds, Vista Research, WebMD, Windrose Consulting Group; Research support: AbbVie, Acorda Therapeutics, AstraZeneca, Axovant Sciences, Biogen, Cavion, Dart NeuroScience, Enterin, F. Hoffman-La Roche, Impax, Intec Pharma, Jazz Pharmaceuticals, Lundbeck, Michael J. Fox Foundation, NeuroDerm, Parkinson’s Foundation, Prexton Therapeutics, Revance, Sunovion. I, W. Ondo, have read the journal’s policy and the authors of this manuscript have the following competing interests: Advisor/consultant/speaker: ACADIA, Acorda, Adamas, Jazz Pharmaceuticals, Neurocrine, Teva, UCB, US WorldMeds; Research support: Biogen, Lilly, Lundbeck, Sun Pharmaceuticals, Sunovian. I, P. Maisonobe, have read the journal’s policy and the authors of this manuscript have the following competing interests: Employment: Ipsen. I, S. Wietek, have read the journal’s policy and the authors of this manuscript have the following competing interests: Employment: Ipsen. I, B. Rubin, have read the journal’s policy and the authors of this manuscript have the following competing interests: Employment (former): Ipsen.